Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A
Autor: | Pietro Giusti, Mila Borri, Morena Zusso, Laura Facci, Stephen D. Skaper, Massimo Barbierato |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Lipopolysaccharides
0301 basic medicine medicine.medical_specialty medicine.medical_treatment Central nervous system lcsh:Medicine Biology Neuroprotection Article 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Internal medicine medicine Animals Humans RNA Messenger Serum amyloid A Acute-Phase Reaction lcsh:Science Cells Cultured Oligodendrocyte Precursor Cells Serum Amyloid A Protein Palmitoylethanolamide Multidisciplinary Microglia Tumor Necrosis Factor-alpha lcsh:R Acute-phase protein Rats Up-Regulation 030104 developmental biology Endocrinology medicine.anatomical_structure Cytokine chemistry nervous system Astrocytes Immunology Tumor necrosis factor alpha lcsh:Q 030217 neurology & neurosurgery |
Zdroj: | Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017) Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/s41598-017-12529-7 |
Popis: | Acute-phase response is a systemic reaction to environmental/inflammatory insults and involves hepatic production of acute-phase proteins, including serum amyloid A (SAA). Extrahepatically, SAA immunoreactivity is found in axonal myelin sheaths of cortex in Alzheimer’s disease and multiple sclerosis (MS), although its cellular origin is unclear. We examined the responses of cultured rat cortical astrocytes, microglia and oligodendrocyte precursor cells (OPCs) to master pro-inflammatory cytokine tumour necrosis factor (TNF)-α and lipopolysaccaride (LPS). TNF-α time-dependently increased Saa1 (but not Saa3) mRNA expression in purified microglia, enriched astrocytes, and OPCs (as did LPS for microglia and astrocytes). Astrocytes depleted of microglia were markedly less responsive to TNF-α and LPS, even after re-addition of microglia. Microglia and enriched astrocytes showed complementary Saa1 expression profiles following TNF-α or LPS challenge, being higher in microglia with TNF-α and higher in astrocytes with LPS. Recombinant human apo-SAA stimulated production of both inflammatory mediators and its own mRNA in microglia and enriched, but not microglia-depleted astrocytes. Co-ultramicronized palmitoylethanolamide/luteolin, an established anti-inflammatory/ neuroprotective agent, reduced Saa1 expression in OPCs subjected to TNF-α treatment. These last data, together with past findings suggest that co-ultramicronized palmitoylethanolamide/luteolin may be a novel approach in the treatment of inflammatory demyelinating disorders like MS. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |